Clin Mol Hepatol.
2023 Jul;29(3):825-827. 10.3350/cmh.2023.0185.
HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Affiliations
-
- 1Division of Hepatology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea
- 2The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2544004
- DOI: http://doi.org/10.3350/cmh.2023.0185
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Application of a Grey Zone for HCV and HIV Immunoassays for Blood Donor Screening: Is It still Necessary?
- Sequential Analysis of Hepatitis Be Antigen Status in Infants Born to Hepatitis Be Antigen-Positive Mothers
- Clinical Evaluation of HBeAg Quantitation Using Enzyme Immunoassay in the Follow-Up of Patients with Chronic Hepatitis B
- Analysis of Reentry Test for the Donors Showing Reactivity or Grey Zone in a HBV Surface Antigen Assay by a Chemiluminescent Immunoassay
- Association between Serum HBeAg Status and Tuberculosis Infection
